PDT Partners’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-22,699
| Closed | -$164K | – | 870 |
|
|
2022
Q2 | $164K | Buy |
+22,699
| New | +$164K | 0.01% | 848 |
|
|
2022
Q1 | – | Sell |
-76,768
| Closed | -$1.23M | – | 957 |
|
|
2021
Q4 | $1.23M | Buy |
76,768
+63,209
| +466% | +$1.01M | 0.09% | 320 |
|
|
2021
Q3 | $218K | Sell |
13,559
-130,152
| -91% | -$2.09M | 0.02% | 673 |
|
|
2021
Q2 | $1.99M | Sell |
143,711
-12,110
| -8% | -$168K | 0.13% | 269 |
|
|
2021
Q1 | $2.28M | Buy |
155,821
+18,421
| +13% | +$269K | 0.16% | 245 |
|
|
2020
Q4 | $2.39M | Sell |
137,400
-190
| -0.1% | -$3.3K | 0.16% | 228 |
|
|
2020
Q3 | $2.52M | Buy |
+137,590
| New | +$2.52M | 0.17% | 193 |
|
|
2020
Q2 | – | Sell |
-26,774
| Closed | -$434K | – | 687 |
|
|
2020
Q1 | $434K | Buy |
26,774
+3,144
| +13% | +$51K | 0.03% | 407 |
|
|
2019
Q4 | $425K | Buy |
+23,630
| New | +$425K | 0.03% | 454 |
|